4//SEC Filing
Wenqing Yao 4
Accession 0001209191-21-043975
CIK 0000879169other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:11 PM ET
Size
10.4 KB
Accession
0001209191-21-043975
Insider Transaction Report
Form 4
INCYTE CORPINCY
Wenqing Yao
Ex VP Discovery Medicinal Chem
Transactions
- Sale
Common Stock
2021-06-29$85.37/sh−27,194$2,321,552→ 94,080 total - Tax Payment
Common Stock
2021-06-28$85.61/sh−22,806$1,952,422→ 121,274 total
Footnotes (5)
- [F1]Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of restricted stock units or earned performance shares previously reported in Table I as common stock.
- [F2]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- [F3]Represents weighted average sale price. Actual sale prices ranged from $84.81 - $85.90.
- [F4]Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- [F5]This includes an aggregate of 58,222 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
Issuer
INCYTE CORP
CIK 0000879169
Entity typeother
Related Parties
1- filerCIK 0001624033
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:11 PM ET
- Size
- 10.4 KB